Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs, AQnowledge Team Up to Make Scientific Literature More Interactive


New England Biolabs said this week that it will work with semantics tool developer Academic Concept Knowledge, or AQnowledge, to include interactive content in peer-reviewed scientific literature.

Andy Bertera, NEB's executive director of marketing, said that his company will provide data about "our library of molecular biology reagents and their applications."

The partners will link NEB's library to scientific papers that are available via Utopia Documents, a free PDF reader that connects research articles with online content.

The tool, which incorporates technology from AQnowledge, has a semantic tagging engine that allows tools and reagents cited in the methods section to be linked to the manufacturer's product page. It also connects literature to underlying public datasets; provides ways to export and graph tabular data; enables manipulation of molecular structures and sequence data; and changes references into hyperlinks, among other features.

According to its developer, Lost Island Labs, Utopia Documents is best suited for reading articles in molecular biology, chemistry, bioinformatics, and other life science domains, although the company intends to broaden its scope.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.